Sonoma Pharmaceuticals Income Statement (2010-2025) | SNOA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	2.16M	3.68M	3.74M	2.90M	2.30M	3.98M	3.33M	2.94M	3.01M	3.43M	2.73M	3.14M	3.44M	3.39M	3.58M	3.56M	3.75M	4.01M	5.60M	4.35M
Cost of Revenue (Quarter)	2.35M	2.23M	2.50M	1.70M	2.20M	2.34M	1.79M	2.11M	2.15M	2.22M	1.74M	1.68M	2.35M	2.08M	2.22M	2.29M	2.23M	2.55M	3.48M	2.70M
Gross Profit (Quarter)	-0.19M	1.45M	1.24M	1.20M	0.10M	1.65M	1.54M	0.83M	0.86M	1.20M	0.99M	1.46M	1.09M	1.31M	1.36M	1.27M	1.53M	1.46M	2.12M	1.65M
Operating items
Research & Development (Quarter)	0.13M	0.08M	0.01M	0.03M	0.00M	0.21M	0.20M		0.20M	0.33M	0.54M	0.60M	0.41M	0.47M	0.51M	0.43M	0.41M	0.59M	0.57M	0.56M
Selling, General & Administrative (Quarter)	2.49M	2.27M	2.19M	2.13M	3.15M	2.29M	2.07M	2.67M	1.81M	2.12M	1.66M	1.70M	2.09M	2.01M	1.71M	1.87M	1.77M	1.97M	1.88M	1.77M
Other Operating Expenses (Quarter)	-0.73M	-0.19M	0.15M		-0.54M	-0.07M	-0.19M	-0.07M	-0.29M	-0.21M	-0.09M	-0.08M	0.05M	0.18M	0.39M	0.11M	0.13M	-0.15M	-0.39M	-0.27M
Operating Expenses (Quarter)	2.62M	2.36M	2.21M	2.16M	3.16M	2.50M	2.27M	2.67M	2.01M	2.44M	2.20M	2.30M	2.50M	2.48M	2.21M	2.30M	2.18M	2.56M	2.46M	2.33M
Operating Income (Quarter)	-2.81M	-0.90M	-0.96M	-0.96M	-3.06M	-0.85M	-0.73M	-1.83M	-1.15M	-1.24M	-1.21M	-0.84M	-1.41M	-1.17M	-0.85M	-1.03M	-0.66M	-1.09M	-0.34M	-0.68M
EBIT (Quarter)	-2.81M	-0.90M	-0.96M	-0.96M	-3.06M	-0.85M	-0.73M	-1.83M	-1.15M	-1.24M	-1.21M	-0.84M	-1.41M	-1.17M	-0.85M	-1.03M	-0.66M	-1.09M	-0.34M	-0.68M
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)	0.00M
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)
Net income details
EBT (Quarter)	-2.81M	-1.10M	-0.10M	-0.94M	-3.28M	-0.92M	-0.92M	-1.91M	-1.44M	-1.45M	-1.30M	-0.92M	-1.36M	-1.00M	-0.46M	-0.92M	-0.53M	-1.24M	-0.73M	-0.95M
Tax Provisions (Quarter)	0.71M		0.01M		0.47M	-0.04M	0.10M	0.03M	-0.13M	-0.03M	0.19M	-0.06M	-0.29M	0.15M	0.15M	0.01M	0.25M	-0.00M	-0.20M	-0.13M
Profit After Tax (Quarter)	-2.77M	-1.10M	-0.10M	-0.94M	-2.94M	-0.89M	-1.02M	-1.94M	-1.31M	-1.42M	-1.48M	-0.87M	-1.07M	-1.14M	-0.61M	-0.93M	-0.78M	-1.24M	-0.53M	-0.82M
Income from Continuing Operations (Quarter)	-3.52M	-1.10M	-0.10M	-0.94M	-3.75M	-0.89M	-1.02M	-1.94M	-1.31M	-1.42M	-1.48M	-0.87M	-1.07M	-1.14M	-0.61M	-0.93M	-0.78M	-1.24M	-0.53M	-0.82M
Consolidated Net Income (Quarter)						-0.89M	-1.02M	-1.94M	-1.31M	-1.42M	-1.48M	-0.87M	-1.07M	-1.14M	-0.61M	-0.93M	-0.78M	-1.24M	-0.53M	-0.82M
Income towards Parent Company (Quarter)						-0.89M	-1.02M	-1.94M	-1.31M	-1.42M	-1.48M	-0.87M	-1.07M	-1.14M	-0.61M	-0.93M	-0.78M	-1.24M	-0.53M	-0.82M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)		-1.10M	-0.10M			-0.89M	-1.02M	-1.94M	-1.31M	-1.42M	-1.48M	-0.87M	-1.07M	-1.14M	-0.61M	-0.93M	-0.78M	-1.24M	-0.53M	-0.82M
Additional items
EPS (Basic) (Quarter)	-1.71	-0.52	-0.04	-0.31		-0.29	-0.33	-0.62	-0.39	-0.29	-5.75	-1.59	0.11	-1.34	-0.59	-0.63	-0.39	-0.76	-0.32	-0.48
EPS (Weighted Average and Diluted) (Quarter)		-0.52	-0.04	-0.31		-0.29	-0.33	-0.62	-0.39	-0.29	-5.75	-1.59	0.11	-1.34	-0.59	-0.63	-0.39	-0.76	-0.32	-0.48
Shares Outstanding (Weighted Average) (Quarter)	2.00M	2.09M	0.00M	0.00M	0.00M	0.00M	0.00M	3.11M	3.39M	4.94M	0.26M	0.55M	0.46M	0.85M	1.03M	1.12M	1.24M	1.64M	1.65M	1.67M
Shares Outstanding (Diluted Average) (Quarter)		2.09M	0.00M	0.00M	0.00M	0.00M	0.00M	3.11M	3.39M	4.94M	0.26M	0.35M	0.46M	0.85M	1.03M	1.46M	1.24M	1.64M	1.65M	1.67M
EBITDA (Quarter)	-4.00M	-0.79M	-0.33M	-1.01M	-2.69M	-0.95M	-1.05M	-1.70M	-0.55M	-0.91M	-1.70M	-0.57M	-0.97M	-2.02M	-1.20M	-1.28M	-0.60M	-0.43M	-0.33M	-0.65M
Interest Expenses (Quarter)		0.00M
Tax Rate (Quarter)	-25.36%		-5.26%		-14.35%	3.80%	-10.91%	-1.78%	9.10%	2.27%	-14.33%	6.18%	21.49%	-14.64%	-31.75%	-0.98%	-46.97%	0.08%	26.95%	13.70%

Research Tools

Sonoma Pharmaceuticals Income Statement (2010-2025) | SNOA

Create an account

Sign In

Reset Password